← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2015Last known activity
Dec 30, 2025
Timeline
2000s
- Jun 1, 2001
GNI Group— Founded
Drugs by trial phase (9 distinct, 22 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Recent trials (24)
- NCT07295873Lead sponsorPhase 1Dec 30, 2025
- NCT07262346Lead sponsorPhase 1Dec 5, 2025
- NCT07263152Lead sponsorPhase 1Dec 1, 2025
- NCT07262333Lead sponsorPhase 1Dec 1, 2025
- NCT06899815Lead sponsorPhase 1May 15, 2025
- NCT05905172Lead sponsorPhase 3Jun 20, 2023
- NCT05704166CollaboratorPhase 2Mar 16, 2023
- NCT05689645Lead sponsorPhase 2Jan 18, 2023
- NCT05531955CollaboratorPhase 2Aug 5, 2022
- NCT05288179Lead sponsorPhase 3Apr 15, 2022
- NCT05115942Lead sponsorPhase 3Nov 20, 2021
- NCT05280873CollaboratorPhase 1Oct 10, 2021
- NCT04820049Lead sponsorPhase 1Feb 8, 2021
- NCT04123769Lead sponsorPhase 1Sep 3, 2019
- NCT04126538Lead sponsorPhase 1Aug 27, 2019
Details
- Founded
- Tokyo, JP Jun 1, 2001
- Last known activity
- Dec 30, 2025